These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18221205)

  • 1. In search of novel AMPA potentiators.
    Francotte P; de Tullio P; Fraikin P; Counerotte S; Goffin E; Pirotte B
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):239-46. PubMed ID: 18221205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor potentiators for the treatment of CNS disorders.
    O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
    Shen Y; Lu T; Yang XL
    Neuroscience; 1999 Mar; 89(3):979-90. PubMed ID: 10199629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive allosteric modulators of AMPA receptors reduce proton-induced receptor desensitization in rat hippocampal neurons.
    Lei S; Orser BA; Thatcher GR; Reynolds JN; MacDonald JF
    J Neurophysiol; 2001 May; 85(5):2030-8. PubMed ID: 11353019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators.
    Pirotte B; Francotte P; Goffin E; Fraikin P; Danober L; Lesur B; Botez I; Caignard DH; Lestage P; de Tullio P
    Curr Med Chem; 2010; 17(30):3575-82. PubMed ID: 20738245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    Johansen TH; Chaudhary A; Verdoorn TA
    Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic excitation mediated by AMPA receptors in rat cerebellar slices is selectively enhanced by aniracetam and cyclothiazide.
    Boxall AR; Garthwaite J
    Neurochem Res; 1995 May; 20(5):605-9. PubMed ID: 7643966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.
    Bernard K; Danober L; Thomas JY; Lebrun C; Muñoz C; Cordi A; Desos P; Lestage P; Morain P
    CNS Neurosci Ther; 2010 Oct; 16(5):e193-212. PubMed ID: 21050420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
    Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
    Patel DR; Young AM; Croucher MJ
    Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
    Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
    J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro.
    Gates M; Ogden A; Bleakman D
    Neuropharmacology; 2001 Jun; 40(8):984-91. PubMed ID: 11406189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
    Quirk JC; Nisenbaum ES
    J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA receptor potentiators: application for depression and Parkinson's disease.
    O'Neill MJ; Witkin JM
    Curr Drug Targets; 2007 May; 8(5):603-20. PubMed ID: 17504104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
    Ahmed AH; Oswald RE
    J Med Chem; 2010 Mar; 53(5):2197-203. PubMed ID: 20163115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of positive allosteric modulators acting on AMPA receptors.
    Jin R; Clark S; Weeks AM; Dudman JT; Gouaux E; Partin KM
    J Neurosci; 2005 Sep; 25(39):9027-36. PubMed ID: 16192394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?
    Yamada KA
    Neurobiol Dis; 1998 Aug; 5(2):67-80. PubMed ID: 9746904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.